Streetbeat News

Products Services

APDN

The Institute of Hematology and Blood Transfusion will present its use of Applied DNA's Linea DNATM technology for the non-viral manufacture of CAR T-cell therapy aimed at treating refractory AML. This showcases a significant application of Applied DNA's technology in advancing cancer treatment.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 1:01 pm

AAPL

MSFT

Apple Inc. is nearing a partnership with OpenAI to integrate ChatGPT into iOS 18 and the iPhone 16, potentially introducing a new revenue stream through a subscription service for advanced AI features. This collaboration, expected to be announced at WWDC on June 10, could significantly enhance Siri's capabilities and attract developers to the Apple ecosystem, also benefiting Microsoft Corp.'s developer ecosystem.

Portfolio Pulse from Rounak Jain

May 13, 2024 | 12:55 pm

OTLK

Outlook Therapeutics has submitted a Marketing Authorization Application for ONS-5010, aimed at treating Wet Age-Related Macular Degeneration (Wet AMD), to the UK's Medicines and Healthcare products Regulatory Agency (MHRA).

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 12:51 pm

BR

KD

Broadridge Financial Solutions, Inc. (BR) is set to acquire Kyndryl's Securities Industry Services (SIS) wealth and capital markets technology platform, aimed at enhancing services for Canadian financial firms. Kyndryl will partner with Broadridge Canada to provide managed services for SIS.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 12:50 pm

SHOT

Safety Shot has announced a collaboration with Gopuff, planning to launch a marketing campaign to support Gopuff's services. Safety Shot products will also be available in Gopuff subsidiaries, indicating a strategic partnership aimed at boosting the visibility and distribution of Safety Shot products through Gopuff's extensive delivery network.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 12:49 pm

BAX

The FDA has approved Baxter's Clinolipid for neonatal and pediatric use, expanding its indication from adults to include preterm neonates. This approval highlights Baxter's ongoing commitment to addressing the nutritional needs of a broader patient demographic.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 12:47 pm

AREC

American Resources Corporation (AREC) through its subsidiary ReElement Technologies, announced a strategic partnership with LVC Global Holdings to enhance metal refining and recycling in Africa. This collaboration aims to redefine refining and recycling practices for rare earth and critical minerals in Emerging & Frontier Markets, particularly in Sub-Saharan Africa, by leveraging innovative technology and market expertise.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 12:42 pm

ABBV

AbbVie has entered into a collaboration and option-to-license agreement with Gilgamesh Pharmaceuticals to develop next-generation neuroplastogens for psychiatric disorders. This partnership combines AbbVie's expertise in psychiatry with Gilgamesh's innovative research platform.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 12:40 pm

ATNM

Actinium Pharmaceuticals, Inc. (ATNM) announced that five abstracts related to its targeted radiotherapies, Iomab-B and Actimab-A, for acute myeloid leukemia (AML) have been accepted for presentation at the 2024 SNMMI Annual Meeting. These therapies have shown improved survival rates in high-risk AML patients, including those with TP53 mutations and prior venetoclax treatment. Additionally, Actinium's novel linker technology is expanding its Antibody Radiation Conjugate pipeline into solid tumor indications.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 12:38 pm

NBY

NovaBay Pharmaceuticals, Inc. (NYSE:NBY) has launched an expanded line of Avenova product bundles aimed at providing relief from multifactorial dry eye symptoms. This move aligns with the growing U.S. market for dry eye treatment, projected to reach $4.86 billion by 2030. The introduction of these product bundles is based on the latest findings and recommendations for personalized treatment of dry eye disease.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 12:38 pm